[HTML][HTML] Best clinical practice in botulinum toxin treatment for children with cerebral palsy

W Strobl, T Theologis, R Brunner, S Kocer… - Toxins, 2015 - mdpi.com
Botulinum toxin A (BoNT-A) is considered a safe and effective therapy for children with
cerebral palsy (CP), especially in the hands of experienced injectors and for the majority of …

[HTML][HTML] Botulinum toxin intervention in cerebral palsy-induced spasticity management: projected and contradictory effects on skeletal muscles

CS Kaya Keles, F Ates - Toxins, 2022 - mdpi.com
Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

[HTML][HTML] Botulinum toxin intervention in cerebral palsy-induced spasticity management: projected and contradictory effects on skeletal muscles

CSK Keles, F Ates - Toxins, 2022 - ncbi.nlm.nih.gov
Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

[HTML][HTML] Off label use of botulinum toxin in children under two years of age: a systematic review

C Druschel, HC Althuizes, JF Funk, R Placzek - Toxins, 2013 - mdpi.com
The treatment of children with cerebral palsy with Botulinum Toxin is considered safe and
effective, but is only approved for children older than two years of age. The effect of BoNT-A …

Use of botulinum toxin A in management of children with cerebral palsy

BC Friedman, RD Goldman - Canadian Family Physician, 2011 - cfp.ca
Question What is the role of intramuscular botulinum toxin injections in the management of
spasticity and related morbidity in children with cerebral palsy? Answer When botulinum …

Botulinum toxin treatment of spasticity targeted to muscle endplates: An international, randomised, evaluator-blinded study comparing two different botulinum toxin …

T Rekand, B Biering-Sörensen, J He, OJ Vilholm… - BMJ open, 2019 - bmjopen.bmj.com
Objectives The therapeutic effects of botulinum neurotoxin (BoNT) are well documented in
upper limb spasticity. However, several factors may influence treatment efficacy, including …

[HTML][HTML] Концепция «ключевых мышц» и раннее начало ботулинотерапии при спастических формах детского церебрального паралича

ОА Клочкова, АЛ Куренков… - Вопросы …, 2017 - cyberleninka.ru
Ботулинотерапия остается наиболее эффективным и безопасным методом снижения
локальной спастичности у пациентов с детским церебральным параличом (ДЦП) …

[PDF][PDF] How can we improve current practice in spastic paresis

K Fheodoroff, J Jacinto, A Geurts, F Molteni… - Eur Neurol …, 2016 - academia.edu
Spastic paresis can arise from a variety of conditions, including stroke, spinal cord injury,
multiple sclerosis, cerebral palsy, traumatic brain injury and hereditary spastic paraplegia. It …

[HTML][HTML] Хемоденервационное лечение препаратом ботулинического токсина типа А спастических форм детского церебрального паралича

АЛ Куренков, СС Никитин, АР Артеменко… - Нервно-мышечные …, 2013 - cyberleninka.ru
Детский церебральный паралич (ДЦП) является одним из самых серьезных
последствий перинатального поражения центральной нервной системы (ЦНС) и самой …

Uso prático da AbobotulinumtoxinA no tratamento de espasticidade em crianças com paralisia cerebral

SR Dorf, CACT Caldas, RHMF Chueire, JH Carvalho… - Acta fisiátrica, 2017 - revistas.usp.br
AbobotulinumtoxinA (ABO) tem sido utilizada para o tratamento da espasticidade em
crianças com paralisia cerebral (PC). Seu uso requer uma administração cuidadosa, quanto …